Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Femara in Post-Menopausal Breast Cancer
NCT00161291Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2005
- Primary completion
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by University of Alabama at Birmingham. Started Jun 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00161291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161291.